Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

Nature Genetics

Volumn 47, Issue 3, 2015, Pages 242-249

  Merker, Matthias ^a   Blin, Camille ^b,c   Mona, Stefano ^b,c   Duforet Frebourg, Nicolas ^d   Lecher, Sophie ^e,f,g   Willery, Eve ^e,f,g   Blum, Michael G B ^d   Rüsch Gerdes, Sabine ^a   Mokrousov, Igor ^h   Aleksic, Eman ⁱ   Allix Béguec, Caroline ^j   Antierens, Annick ^k   Augustynowicz Kopeć, Ewa ^l   Ballif, Marie ^m   Barletta, Francesca ⁿ   Beck, Hans Peter ^o   Barry, Clifton E ^p   Bonnet, Maryline ^q   Borroni, Emanuele ^r   Campos Herrero, Isolina ^s   Cirillo, Daniela ^r   Cox, Helen ^t   Crowe, Suzanne ^i,u,v   Crudu, Valeriu ^w   Diel, Roland ^x   Drobniewski, Francis ^y,z   Fauville Dufaux, Maryse ^aa   Gagneux, Sébastien ^o   Ghebremichael, Solomon ^ab   Hanekom, Madeleine ^ac   Hoffner, Sven ^ab   Jiao, Wei Wei ^ad   Kalon, Stobdan ^ae   Kohl, Thomas A ^a   Kontsevaya, Irina ^af   Lillebæk, Troels ^ag   Maeda, Shinji ^ah   Nikolayevskyy, Vladyslav ^y,z   Rasmussen, Michael ^ag   Rastogi, Nalin ^ai   Samper, Sofia ^aj   Sanchez Padilla, Elisabeth ^q   Savic, Branislava ^ak   Shamputa, Isdore Chola ^p   Shen, Adong ^ad   Sng, Li Hwei ^al   Stakenas, Petras ^am   Toit, Kadri ^an   Varaine, Francis ^k   Vukovic, Dragana ^ak   Wahl, Céline ^j   Warren, Robin ^ac   Supply, Philip ^e,f,g,j   Niemann, Stefan ^a,ao   Wirth, Thierry ^b,c   more..

^a RESEARCH CENTER BORSTEL   (Germany)

^b PSL RESEARCH UNIVERSITY   (France)

^c Cedex   (France)

^d UNIV GRENOBLE ALPES   (France)

^e INSERM U1019   (France)

^f CNRS   (France)

^g UNIV LILLE   (France)

^h ST PETERSBURG PASTEUR INSTITUTE   (Russian Federation)

ⁱ BURNET INSTITUTE   (Australia)

^j Genoscreen   (France)

^k MÉDECINS SANS FRONTIÈRES   (Switzerland)

^l NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^m UNIVERSITY OF BERN   (Switzerland)

ⁿ INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^o SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^p NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^q EPICENTRE   (France)

^r SAN RAFFAELE HOSPITAL   (Italy)

^s HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^t UNIVERSITY OF CAPE TOWN   (South Africa)

^u ALFRED HOSPITAL   (Australia)

^v MONASH UNIVERSITY   (Australia)

^w Phthisiopneumology Institute   (Moldova)

^x UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^y PUBLIC HEALTH ENGLAND   (United Kingdom)

^z IMPERIAL COLLEGE LONDON   (United Kingdom)

^aa SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^ab SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^ac UNIVERSITY OF STELLENBOSCH   (South Africa)

^ad CAPITAL MEDICAL UNIVERSITY   (China)

^ae US Agency for International Development Quality Health Care Project   (Kyrgyzstan)

^af Samara Oblast Tuberculosis Dispensary   (Russian Federation)

^ag STATENS SERUM INSTITUT   (Denmark)

^ah RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^ai WORLD HEALTH ORGANIZATION   (Switzerland)

^aj HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^ak UNIVERSITY OF BELGRADE   (Serbia)

^al SINGAPORE GENERAL HOSPITAL   (Singapore)

^am VILNIUS UNIVERSITY   (Lithuania)

^an TARTU UNIVERSITY HOSPITAL   (Estonia)

^ao German Center for Infection Research   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; CHINA; EPIDEMIC; GENETIC ANALYSIS; GENOME; HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYLOGENY; POPULATION DYNAMICS; POPULATION SIZE; PRIORITY JOURNAL; USSR; BACTERIAL GENOME; CLASSIFICATION; EVOLUTION; GENETICS; GENOTYPE; HEALTH; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR EVOLUTION; MUTATION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

BIOLOGICAL EVOLUTION; EVOLUTION, MOLECULAR; GENOME, BACTERIAL; GENOTYPE; GLOBAL HEALTH; HUMANS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84928483773     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3195     Document Type: Article

References (59)

1. Global Tuberculosis Report. (World Health Organization, Geneva, 2013).
2. Klopper, M. et al. Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa. Emerg. Infect. Dis. 19, 449-455 (2013).
3. Casali, N. et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat. Genet. 46, 279-286 (2014).
4. Stoffels, K. et al. From multidrug-to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study. PLoS ONE 8, e63128 (2013).
5. Niemann, S. et al. Mycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia. J. Clin. Microbiol. 48, 3544-3550 (2010).
6. Mokrousov, I. Insights into the origin, emergence, and current spread of a successful Russian clone of Mycobacterium tuberculosis. Clin. Microbiol. Rev. 26, 342-360 (2013).
7. Munsiff, S.S. et al. Persistence of a highly resistant strain of tuberculosis in New York City during 1990-1999. J. Infect. Dis. 188, 356-363 (2003).
8. Cowley, D. et al. Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clin. Infect. Dis. 47, 1252-1259 (2008).
9. Caminero, J.A. et al. Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island. Am. J. Respir. Crit. Care Med. 164, 1165-1170 (2001).
10. Ford, C.B. et al. Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat. Genet. 45, 784-790 (2013).
11. Comas, I. & Gagneux, S. A role for systems epidemiology in tuberculosis research. Trends Microbiol. 19, 492-500 (2011).
12. Casali, N. et al. Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Res. 22, 735-745 (2012).
13. Glynn, J.R., Whiteley, J., Bifani, P.J., Kremer, K. & van Soolingen, D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg. Infect. Dis. 8, 843-849 (2002).
14. Bifani, P.J., Mathema, B., Kurepina, N.E. & Kreiswirth, B.N. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol. 10, 45-52 (2002).
15. Parwati, I., van Crevel, R. & van Soolingen, D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect. Dis. 10, 103-111 (2010).
16. Hanekom, M. et al. Mycobacterium tuberculosis Beijing genotype: a template for success. Tuberculosis (Edinb.) 91, 510-523 (2011).
17. de Jong, B.C. et al. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J. Infect. Dis. 198, 1037-1043 (2008).
18. Kato-Maeda, M. et al. Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig. Clin. Vaccine Immunol. 19, 1227-1237 (2012).
19. Weniger, T., Krawczyk, J., Supply, P., Niemann, S. & Harmsen, D. MIRU-VNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria. Nucleic Acids Res. 38, W326-W331 (2010).
20. Plikaytis, B.B. et al. Multiplex PCR assay specific for the multidrug-resistant strain W of Mycobacterium tuberculosis. J. Clin. Microbiol. 32, 1542-1546 (1994).
21. Kalinowski, S.T. Counting alleles with rarefaction: private alleles and hierarchicalsampling design. Conserv. Genet. 5, 539-543 (2004).
22. Supply, P., Niemann, S. & Wirth, T. On the mutation rates of spoligotypes and variable numbers of tandem repeat loci of Mycobacterium tuberculosis. Infect. Genet. E vol. 11, 251-252 (2011).
23. Reyes, J.F. & Tanaka, M.M. Mutation rates of spoligotypes and variable numbers of tandem repeat loci in Mycobacterium tuberculosis. Infect. Genet. E vol. 10, 1046-1051 (2010).
24. Ragheb, M.N. et al. The mutation rate of mycobacterial repetitive unit loci in strains of M. tuberculosis from cynomolgus macaque infection. BMC Genomics 14, 145 (2013).
25. Comas, I., Homolka, S., Niemann, S. & Gagneux, S. Genotyping of genetically monomorphic bacteria: DNA sequencing in mycobacterium tuberculosis highlights the limitations of current methodologies. PLoS ONE 4, e7815 (2009).
26. Walker, T.M. et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect. Dis. 13, 137-146 (2013).
27. Nieselt-Struwe, K. & von Haeseler, A. Quartet-mapping, a generalization of the likelihood-mapping procedure. Mol. Biol. E vol. 18, 1204-1219 (2001).
28. Namouchi, A., Didelot, X., Schock, U., Gicquel, B. & Rocha, E.P. After the bottleneck: genome-wide diversification of the Mycobacterium tuberculosis complex by mutation, recombination, and natural selection. Genome Res. 22, 721-734 (2012).
29. Roetzer, A. et al. Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study. PLoS Med. 10, e1001387 (2013).
30. Ford, C.B. et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat. Genet. 43, 482-486 (2011).
31. Comas, I. & Gagneux, S. The past and future of tuberculosis research. PLoS Pathog. 5, e1000600 (2009).
32. Colditz, G.A. et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. J. Am. Med. Assoc. 271, 698-702 (1994).
33. Holden, C. Stalking a killer in Russia's prisons. Science 286, 1670 (1999).
34. Bifani, P.J. et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. J. Am. Med. Assoc. 275, 452-457 (1996).
35. Parish, T. et al. Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis. Infect. Immun. 71, 1134-1140 (2003).
36. Duforet-Frebourg, N., Bazin, E. & Blum, M.G. Genome scans for detecting footprints of local adaptation using a Bayesian factor model. Mol. Biol. E vol. 31, 2483-2495 (2014).
37. Maloney, E. et al. The two-domain LysX protein of Mycobacterium tuberculosis is required for production of lysinylated phosphatidylglycerol and resistance to cationic antimicrobial peptides. PLoS Pathog. 5, e1000534 (2009).
38. Sirakova, T.D., Fitzmaurice, A.M. & Kolattukudy, P. Regulation of expression of mas and fadD28, two genes involved in production of dimycocerosyl phthiocerol, a virulence factor of Mycobacterium tuberculosis. J. Bacteriol. 184, 6796-6802 (2002).
39. Ebrahimi-Rad, M. et al. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg. Infect. Dis. 9, 838-845 (2003).
40. Etienne, G. et al. Identification of the polyketide synthase involved in the biosynthesis of the surface-exposed lipooligosaccharides in mycobacteria. J. Bacteriol. 191, 2613-2621 (2009).
41. Ahmad, S., El-Shazly, S., Mustafa, A.S. & Al-Attiyah, R. Mammalian cell-entry proteins encoded by the mce3 operon of Mycobacterium tuberculosis are expressed during natural infection in humans. Scand. J. Immunol. 60, 382-391 (2004).
42. Li, X.Z., Zhang, L. & Nikaido, H. Effux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 48, 2415-2423 (2004).
43. Meikle, V. et al. Identification of novel Mycobacterium bovis antigens by dissection of crude protein fractions. Clin. Vaccine Immunol. 16, 1352-1359 (2009).
44. de Vos, M. et al. Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission. Antimicrob. Agents Chemother. 57, 827-832 (2013).
45. Comas, I. et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifes compensatory mutations in RNA polymerase genes. Nat. Genet. 44, 106-110 (2012).
46. Comas, I. et al. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat. Genet. 45, 1176-1182 (2013).
47. Fuller, D.Q. et al. The domestication process and domestication rate in rice: spikelet bases from the Lower Yangtze. Science 323, 1607-1610 (2009).
48. Fang, J. Atlas for Sustainability in Polynesian Island Cultures and Ecosystems (Sea Education Association, 2013).
49. Laruelle, M. & Peyrouse, S. Cross-border minorities as cultural and economic mediators between China and Central Asia. China and Eurasia Forum Quarterly 7, 93-119 (2009).
50. Drolet, G.J. World War I and tuberculosis. A statistical summary and review. Am. J. Public Health Nations Health 35, 689-697 (1945).
51. Bryant, J.M. et al. Inferring patient to patient transmission of Mycobacterium tuberculosis from whole genome sequencing data. BMC Infect. Dis. 13, 110 (2013).
52. Aguilar, D. et al. Mycobacterium tuberculosis strains with the Beijing genotype demonstrate variability in virulence associated with transmission. Tuberculosis (Edinb.) 90, 319-325 (2010).
53. Ribeiro, S.C. et al. Mycobacterium tuberculosis strains of the modern sublineage of the Beijing family are more likely to display increased virulence than strains of the ancient sublineage. J. Clin. Microbiol. 52, 2615-2624 (2014).
54. Gioffré, A. et al. Mutation in mce operons attenuates Mycobacterium tuberculosis virulence. Microbes Infect. 7, 325-334 (2005).
55. Stavrum, R. et al. Modulation of transcriptional and infammatory responses in murine macrophages by the Mycobacterium tuberculosis mammalian cell entry (Mce) 1 complex. PLoS ONE 6, e26295 (2011).
56. Ahidjo, B.A. et al. VapC toxins from Mycobacterium tuberculosis are ribonucleases that differentially inhibit growth and are neutralized by cognate VapB antitoxins. PLoS ONE 6, e21738 (2011).
57. Osório, N.S. et al. Evidence for diversifying selection in a set of Mycobacterium tuberculosis genes in response to antibiotic- and nonantibiotic-related pressure. Mol. Biol. E vol. 30, 1326-1336 (2013).
58. Zhang, H. et al. Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifes genes and intergenic regions associated with drug resistance. Nat. Genet. 45, 1255-1260 (2013).
59. Farhat, M.R. et al. Genomic analysis identifes targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis. Nat. Genet. 45, 1183-1189 (2013).